Innovation Conference & Showcase - Agenda
Subject to change.
ICS Chair Address - Innovation in Health Sciences: People, Processes, and Policy
Prashant Natarajan, Chair, ICS
Track 1: Precision Medicine
Opening Keynote 1 - Intel
Arjun is the Vice President, General Manager, Artificial Intelligence Software and Lab at Intel. Prior to Nervana Systems’ acquisition by Intel in August 2016, he was co-founder & VP Algorithms at Nervana heading Machine Learning Software & Data Science. His research work has spanned neurophysiology and large scale machine learning. Arjun holds a BS in computer science from Caltech and a PhD in neuroscience from Brown University. He completed postdoctoral training at Boston Children’s Hospital and Harvard Medical School.
Precision Medicine Panel
Sean Sigmon was most recently National Director of Business Development and Strategy for Oracle’s Health Sciences business focused on Personalized Medicine. Previously, Sean was VP of Sales and Business Development at Translational Software and held senior marketing and sales leadership roles for Microsoft, Philips Healthcare, and Boehringer Ingelheim. He’s worked in healthcare for more than 20 years. He enjoys helping executives and clinicians understand and embrace new therapies, devices, software and ways of working.
Sean holds a BA in Economics from the University of Washington and a MBA from Seattle University, and is an Executive Trustee at BloodworksNW (the largest blood services and research organization in the northwest).
Dr. Oscar E. Streeter, Jr. is a board certified radiation oncologist Chief Medical & Scientific Officer for the CA Division of the American Cancer Society. Dr. Streeter’s prestigious 32 year medical career includes corporate, academic and private practice with expertise in integrative cancer care. He is an internationally recognized expert in the treatment of breast cancer and implant radiation (brachytherapy), as well as a certified acupuncturist. Dr. Streeter attended Medical School and completed his residency at Howard University, and spent 18 years at the Keck School of Medicine at the University of Southern California holding positions as Associate Professor, Residency Program Director and Chief of the Radiation Oncology Department for several years at LAC+USC Medical Center and Chief of Service in Radiation Oncology at USC/Norris Cancer Hospital.
Dr. Joe Pinzone
Dr. Pinzone is CEO & Medical Director at AMAI an Innovative medical and Wellness Practice, Inc. AMAI has a team of healthcare practitioners including dietitians, personal trainers, and life coaches who provide a 360 degree view of an individual's health, and help set and achieve health and life goals. AMAI is beyond concierge medicine. He also serves as Assistant Clinical Professor of Medicine at the David Geffen School of Medicine at UCLA.
In 2009 Dr. Pinzone was recruited to the Hemotology/Oncology Therapeutic Area at Amgen, Inc. He served as the North American Medical Leader for Denosumab Oncology and led the Medical Affairs team that launched XGEVA®. He interfaced with the Brand Team and the Regional Medical Liaisons to communicate medical information. He also oversaw the Investigator-Sponsored Study program. In 2012 Dr. Pinzone transitioned to the Bone Therapeutic Area as Clinical Research Medical Director for Prolia®, serving as medical lead for clinical studies, RML educational activities and the ISS Program.
Track 2: Health Innovation & Public-Private Partnerships
Track 2 Keynote - Health Innovation & Public-Private Partnerships
Joel spent twelve years on Capitol Hill as professional staff, where he helped enact nine laws, including the 2002 Trade Act, which created health care tax credits, the 2003 law that established the Medicare prescription drug benefit and Health Savings Accounts, the 2005 Deficit Reduction Act and the 2006 Tax Reform and Health Care Act, which reformed Medicare payment policies.
Joel spent six years as staff on the Committee on Ways and Means, first as Professional Staff and then as Staff Director of the Health Subcommittee.
Joel is on the Boards of Directors of CAHC, the Newborn Foundation, Samaritan Inns, Arlington Bridge Builders, and the Citizen and Soldier Foundation. He is also on the National Advisory Board of the Cancer Support Community. Joel holds a BS in Economics from the American University and is the co-author of the book, Facts and Figures on Government Finance.
Track 2 Panel - Health Innovation & Public-Private Partnerships
Prashant Natarajan is Director of Innovation & Strategy at Oracle in the Health Sciences Global Business Unit. He is a recognized thought leader (#HIT100) and customer advisor on analytics, Blockchain, big + little data, and machine/deep learning. He is passionate about helping organizations maximize their technology investments to improve patient care, provider satisfaction, personal wellness, and health policy.
Prashant is a popular keynote speaker and best-selling author on emerging technologies and their applications in multiple verticals including health sciences, e-commerce, and manufacturing. His HIMSS books on Big Data & Machine Learning (2017) & Business Intelligence (2012) are top-sellers in the genre (www.BigDataCXO.com) He has co-authored chapters on precision medicine, communications in technology environments, and is currently Lead Editor of “Demystifying AI for the Enterprise” (2018). Prashant serves as Industry Advisor for the CIAPM project at UCSF and on the Board of Advisors at CAHC. He teaches Applied Deep/Machine Learning & Artificial Intelligence as Co-Faculty Instructor at Stanford University, Palo Alto, CA.
Elizabeth Baca serves as the Senior Health Advisor in the Governor’s Office of Planning and Research (OPR) and provides vision, leadership and oversight for the California Initiative to Advance Precision Medicine (CIAPM). She is engaged in innovation in the public sector to foster health through multiple projects including public-private partnerships, big data, and healthy planning. Her portfolio involves working across agencies and departments in California as well as with many foundation, non-profit, for-profit groups, and entrepreneurs.
Previously, Dr. Baca served on the General Pediatric Faculty at Stanford Medical School and directed the Community Pediatric and Child Advocacy Rotation. Dr. Baca studied health policy at Universidad Simon Bolivar in Venezuela. She completed her Masters in Public Administration at Harvard Kennedy School of Government and her medical degree at Harvard Medical School. Dr. Baca completed her pediatric residency in the Pediatric Leadership for the Underserved (PLUS) program at UC San Francisco.
Marc Perlman is the Managing Director and Global Business Development Leader for Deloitte LLP. With more than 33 years in healthcare, Marc brings deep experience in global healthcare having worked closely with governments, regions/provinces, health systems, payer organizations, system integrators and vertical software companies. He has participated in multiple international trade missions with the US Department of Commerce as well as international engagements with the US Chamber of Commerce. He currently serves an advisory board member for the USA Health Alliance (USAHA), and the Council for Affordable Healthcare (CAHC).
NorCal County health innovation leader
LUNCH: Boxed lunch at Intel cafeteria
ICS Co-Chair Update
Danielle Siarri, NorCal HIMSS
Chapter Education & Professional Growth
Margit Chapman, NorCal HIMSS
Track 3: Big Data & AI in Healthcare
Track 3 Keynote
Dr. Pratik Mukherjee
Pratik Mukherjee, MD, PhD, is a Professor in Residence in the Department Radiology and Biomedical Imaging, Bioengineering, and he is an attending neuroradiologist at the University of California, San Francisco. He is the Director of the Center for Imaging of Neurodegenerative Disease (CIND) based at the San Francisco VA Medical Center. He also directs the Neural Connectivity Laboratory (NCL) at UCSF China Basin.
Dr. Mukherjee received his PhD in Neuroscience from Rockefeller University, New York in 1994 and his MD from Cornell University, New York, in 1995. He completed his internship in Internal Medicine at New York Hospital - Cornell Medical Center, followed by a residency in Radiology and fellowship in Neuroradiology at Washington University Medical Center in St. Louis, Missouri, completed in 2002. Dr. Mukherjee’s primary clinical research is the study of neurodevelopmental disorders and traumatic brain injury (TBI) using advanced MRI. His research has been focused on technical development, neuroscience and clinical applications of advanced imaging methods for mapping structure and function of the human brain. He has published over 80 peer-reviewed papers.
Track 3 Panel - Demystifying Big Data, Machine Learning & AI for Healthcare
Zeeshan Syed is the Inaugural Director of the Clinical Inference and Algorithms Program at Stanford Health Care and a Clinical Associate Professor at the Stanford University School of Medicine. Before joining Stanford in 2016, Dr. Syed was an Associate Professor with Tenure in Computer Science and Engineering at the University of Michigan, where he was a Principal Investigator for the Artificial Intelligence Laboratory and led the Computational Biomarker Discovery and Clinical Inference Group. Dr. Syed received SB and MEng degrees in Electrical Engineering and Computer Science at MIT, and a PhD through a joint program between MIT’s School of Engineering and Harvard Medical School in Computer Science and Biomedical Engineering. Dr. Syed’s research investigates the design and application of advanced healthcare-specialized machine learning and artificial intelligence technologies for clinical effectiveness, high-value care and population health, and has featured at top machine learning and artificial intelligence conferences (NIPS, ICML, AAAI, KDD) as well as in the media (Wired, CBS, NPR, WSJ, Technology Review, ZDNet). Dr. Syed is the recipient of multiple national awards for his scholarship activities, including the prestigious CAREER award from the National Science Foundation. Dr. Syed is also actively engaged with the healthcare analytics industry, having been part of the core early-stage team for the Google[X] Life Sciences initiative (now Verily) and as a founder of HEALTH[at]SCALE Technologies.
Carla Leibowitz heads strategy and marketing at Arterys, a cloud/artificial intelligence company in the medical imaging space. She has an MBA from the Stanford Graduate School of Business and engineering degrees from both MIT and Stanford.
Prior to joining Arterys, Carla spent 3 years at Bain & Company, consulting for top biotech, diagnostic and hospital clients. Before to that, Carla designed medical devices and led device development teams at several companies
Tatyana Kanzaveli has gone from a programmer to senior executive at Big 5 to founder and CEO of a startup company along her 20 year career, recognized as a thought leader, mentor for her ability to guide Fortune 500 and startup companies through business challenges. She’s worked for major companies like PricewaterhouseCoopers and Fujitsu and startups in the early days of the Web. Tatyana has been recognized as one of the top 10 Influential Women in Healthcare IT in 2015.
Today, she is the founder and CEO of Open Health Network, a mentor at 500Startups and Richard Branson Entrepreneurs Centre and serves on boards for private companies. She also is licensee and organizer of highly notable TEDxBayArea conferences, She is a frequent speaker at US and International conferences on innovation, entrepreneurship and digital health. Tatyana has been featured in the White House blog , spoke at the United Nations, presented at the first White House Demo Day hosted by the President Obama.
Riju Pahwa, Head of SW Engineering, ZAP Surgical – bio to follow
Networking Break and Exhibit Hall
Topics in Innovation (1/2 hour each)
Incorporating the Patient Voice - Participation, Collaboration and Empowerment
Bryce Olson is the Global Marketing Director for Intel’s Health and Life Sciences group. One of the areas he focuses on is bringing technology and science together in the exciting area of genomics and precision medicine with a powerful message on how this saves lives. Genomic sequencing and precision medicine gave him a life he didn’t think he’d get to live. Bryce is inspired by connecting the advances in life sciences into clinical settings and helping patients understand these new opportunities.
He is a sought after keynote speaker both locally and nationally, and his story has been covered by both local and national media. Bryce also started FACTS (‘Fighting Advanced Cancer Through Songs’), a movement that uses the power of music to build awareness for a new way to fight cancer and bring molecular testing and precision medicine to other advanced cancer patients. In 2017, Bryce wrote and co-produced a rock-n-roll album in support of the FACTS movement that brought together a variety of Portland, Oregon based musicians and singers including Jenny Conlee from the Decemberists, Martha Davis from the Motels, Pete Krebs, and Michelle DeCourcy – all four are cancer survivors.
Staying at the Forefront of Technology - MemorialCare Technology Center
Imran Salim has spent nearly 30 years helping organizations leverage technology to improve business outcomes and create efficiency. Imran joined Sirius in 2000, and became the senior vice president of sales for the company’s Western region. During this time, he led a diverse group of sales and technical teams to improve both client satisfaction and the Sirius business. Imran oversaw the creation of the Sirius Healthcare practice in 2014, and has managed it since. He leads a national healthcare team that focuses on finding the right mix of technologies, consulting and solution partnerships to meet the demanding needs of healthcare clients. He also led the effort to create the MemorialCare Technology and Training Center Powered by Sirius (MTC), a state-of-the-art technology facility for healthcare IT innovation, experimentation, meeting and training, in Orange County, California. Mr. Salim holds a Bachelor of Business Administration in Marketing and Finance from California State University.
Fireside Chat with Dr. Joe Pinzone
|5:20||ICS 2018 Close|